Distinct high resolution genome profiles of early onset and late onset colorectal cancer integrated with gene expression data identify candidate susceptibility loci.
about
tRNA methyltransferase homolog gene TRMT10A mutation in young onset diabetes and primary microcephaly in humansTransfer RNA methytransferases and their corresponding modifications in budding yeast and humans: activities, predications, and potential roles in human healthEarly-onset colorectal cancer: a separate subset of colorectal cancerModify or die?--RNA modification defects in metazoansA genome-wide study of cytogenetic changes in colorectal cancer using SNP microarrays: opportunities for future personalized treatmentContinuing difficulties in interpreting CNV data: lessons from a genome-wide CNV association study of Australian HNPCC/lynch syndrome patients.Unsupervised Analysis of Array Comparative Genomic Hybridization Data from Early-Onset Colorectal Cancer Reveals Equivalence with Molecular Classification and Phenotypes.DNA sequence profiles of the colorectal cancer critical gene set KRAS-BRAF-PIK3CA-PTEN-TP53 related to age at disease onset.MDM2 antagonist Nutlin-3a potentiates antitumour activity of cytotoxic drugs in sarcoma cell lines.Frequent copy number gains at 1q21 and 1q32 are associated with overexpression of the ETS transcription factors ETV3 and ELF3 in breast cancer irrespective of molecular subtypes.OTUB1 promotes metastasis and serves as a marker of poor prognosis in colorectal cancer.Molecular subtypes in stage II-III colon cancer defined by genomic instability: early recurrence-risk associated with a high copy-number variation and loss of RUNX3 and CDKN2A.Transfer RNA detection by small RNA deep sequencing and disease association with myelodysplastic syndromes.Classifying early-onset colorectal cancer according to tumor location: new potential subcategories to exploreOncogenicity of the developmental transcription factor Sox9.A genome-wide assessment of rare copy number variants in colorectal cancer.Prognostic factors in relation to racial disparity in advanced colorectal cancer survival.The somatic POLE P286R mutation defines a unique subclass of colorectal cancer featuring hypermutation, representing a potential genomic biomarker for immunotherapy.Somatic gene copy number alterations in colorectal cancer: new quest for cancer drivers and biomarkers.Transfer RNA methyltransferases with a SpoU-TrmD (SPOUT) fold and their modified nucleosides in tRNA.CpG island methylator phenotype identifies high risk patients among microsatellite stable BRAF mutated colorectal cancers.A micro-RNA expression signature for human NAFLD progressionReplacement of the myotonic dystrophy type 1 CTG repeat with 'non-CTG repeat' insertions in specific tissues.Altered primary chromatin structures and their implications in cancer development.Deoxyribonucleotide Triphosphate Metabolism in Cancer and Metabolic Disease.CLC and IFNAR1 are differentially expressed and a global immunity score is distinct between early- and late-onset colorectal cancer
P2860
Q24339464-1FAE2B29-0E06-4558-B8B9-30C3E42E251CQ26849751-C24AFEC3-631B-4B81-A601-CADD17DCBCAFQ27012841-B2922DF1-A01E-4351-A2B8-B6B104E0CB4EQ28087742-313EFFBC-5507-4A91-8B98-37D8A41CAAA7Q28480975-473352AA-DA63-44DA-A83F-7B66A841CFF1Q30607430-3E30C6E9-2ADB-43B7-838A-B30D21617E99Q31149689-13E6EFE0-79C6-4482-AED8-4FC3AC1AEF47Q33754380-DA31BBD3-D263-467A-B3C6-FABEEF76399EQ33915624-CCC62D9F-8DB8-4EC3-9927-2F357FE01F80Q34323234-29503F47-876C-4107-9D9C-B2ACF331F7D1Q35154448-9FCC75FC-5776-4B12-9DCA-4785EE415B4DQ35447606-60337290-82BA-467E-9918-55D81A5B8B92Q35785942-B015E08E-8944-4CBA-A937-D82311EEAE2BQ35993186-4703814C-5581-46DA-A754-DDB3B37A3187Q36043468-98B81D93-ED99-42D6-B28F-0CF245994A76Q36413474-CA90188D-CC3A-4E37-B927-CE2E9F35F3C3Q37394330-8A8F23D8-2428-4910-B428-C60CBA9FD57FQ37708839-AE098E39-D6C5-491B-9D7F-A53C623E73A8Q38563527-23CB8F63-1241-487D-BB8E-A188C5FF8D39Q38750005-21A7C7E9-4CC4-44CB-8D4A-8E8F8EA62CE0Q41066289-B6181C5C-91B6-4CB5-BC22-A992FEDAFF08Q41647903-B570C611-C409-4A91-9BD3-B509D8310B0CQ42154820-35CD37F7-E3B0-4065-82EB-AFAE59973529Q52878923-3E1C1DBE-9DB9-461C-979B-3CB04196AB3EQ53688741-4A114332-4D10-4FEA-BC79-9252852167E7Q58048546-D15C10A5-9C57-428E-BF3C-2EFDE6F2F4CB
P2860
Distinct high resolution genome profiles of early onset and late onset colorectal cancer integrated with gene expression data identify candidate susceptibility loci.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Distinct high resolution genom ...... candidate susceptibility loci.
@ast
Distinct high resolution genom ...... candidate susceptibility loci.
@en
Distinct high resolution genom ...... candidate susceptibility loci.
@nl
type
label
Distinct high resolution genom ...... candidate susceptibility loci.
@ast
Distinct high resolution genom ...... candidate susceptibility loci.
@en
Distinct high resolution genom ...... candidate susceptibility loci.
@nl
prefLabel
Distinct high resolution genom ...... candidate susceptibility loci.
@ast
Distinct high resolution genom ...... candidate susceptibility loci.
@en
Distinct high resolution genom ...... candidate susceptibility loci.
@nl
P2093
P2860
P50
P356
P1433
P1476
Distinct high resolution genom ...... candidate susceptibility loci.
@en
P2093
Espen Thiis-Evensen
INFAC-study group
Marianne A Merok
Marianne Berg
Trude H Agesen
P2860
P2888
P356
10.1186/1476-4598-9-100
P407
P577
2010-05-06T00:00:00Z
P5875
P6179
1028033947